Notably, most basal-like breast cancer patients belong to the group of triple-negative breast cancer (TNBC), which is featured by a lack of estrogen receptor (ER), progesterone receptor (PR), and HER2. The gene discussed is ERBB2; the disease is breast carcinoma.